About

DVS Sciences Inc. is an analytical equipment and reagents development company that produces and markets the
CyTOF^®, a high throughput mass cytometer for individual cell analysis based on a novel elemental mass-spectrometry detection technology, and the MAXPAR^® system of reagents related to massively multi-parametric assays. Both are covered by company patents.

DVS is committed to developing robust, innovative instrumentation, reagents and consumables that accelerate medical research and transform drug discovery via highly multiplexed bio-analysis.

The technology of the  CyTOF^® and MAXPAR^® was originally conceived and patented by the principals of DVS Sciences while they were working at MDS Sciex (now AB Sciex). They moved to the University of Toronto in 2005 to participate in the further development of the technology. That project developed a further 9 inventions that relate to CyTOF^® and MAXPAR^®. All of the IP has been licensed to DVS Sciences Inc.